Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. HUBS
3. SPY
4. NUE
5. AAPL
6. AZN
7. TRMD
8. RARE
9. RTB
10. INTU

Go back to Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension
GALECTIN (NASDAQ: GALT) Delayed: 3.75 +0.04 (1.08%)
Previous Close $3.71    52 Week High $3.05 
Open $3.75    52 Week Low $0.49 
Day High $3.76    P/E N/A 
Day Low $3.68    EPS $-1.32 
Volume 35,112